{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:13:42Z","timestamp":1790871222805,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,2,13]],"date-time":"2010-02-13T00:00:00Z","timestamp":1266019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s00259-009-1370-z","type":"journal-article","created":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T08:31:19Z","timestamp":1265963479000},"page":"1368-1376","source":"Crossref","is-referenced-by-count":65,"title":["PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A\u2033-DTPA-cetuximab"],"prefix":"10.1007","volume":"37","author":[{"given":"Tapan K.","family":"Nayak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste A. S.","family":"Regino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane E.","family":"Milenic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayhan","family":"Garmestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwamena E.","family":"Baidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence P.","family":"Szajek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin W.","family":"Brechbiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,13]]},"reference":[{"key":"1370_CR1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1053\/j.seminoncol.2006.04.003","volume":"33","author":"J Mendelsohn","year":"2006","unstructured":"Mendelsohn J, Baselga J. Epidermal growth factor receptor targeting in cancer. Semin Oncol 2006;33:369\u201385.","journal-title":"Semin Oncol"},{"key":"1370_CR2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1677\/erc.1.00600","volume":"11","author":"PM Harari","year":"2004","unstructured":"Harari PM. Epidermal growth factor receptor inhibition strategies in oncology. Endocr Relat Cancer 2004;11:689\u2013708.","journal-title":"Endocr Relat Cancer"},{"key":"1370_CR3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ctrv.2009.02.001","volume":"35","author":"J Capdevila","year":"2009","unstructured":"Capdevila J, Elez E, Macarulla T, Ramos FJ, Ruiz-Echarri M, Tabernero J. Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment. Cancer Treat Rev 2009;35:354\u201363.","journal-title":"Cancer Treat Rev"},{"key":"1370_CR4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","volume":"351","author":"D Cunningham","year":"2004","unstructured":"Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004;351:337\u201345.","journal-title":"N Engl J Med"},{"key":"1370_CR5","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-08-0449","volume":"14","author":"N Personeni","year":"2008","unstructured":"Personeni N, Fieuws S, Piessevaux H, De Hertogh G, De Schutter J, Biesmans B, et al. Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: a fluorescent in situ hybridization study. Clin Cancer Res 2008;14:5869\u201376.","journal-title":"Clin Cancer Res"},{"key":"1370_CR6","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1200\/JCO.2008.20.2796","volume":"27","author":"F Loupakis","year":"2009","unstructured":"Loupakis F, Pollina L, Stasi I, Ruzzo A, Scartozzi M, Santini D, et al. PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer. J Clin Oncol 2009;27:2622\u20139.","journal-title":"J Clin Oncol"},{"key":"1370_CR7","first-page":"1530","volume":"42","author":"X Wen","year":"2001","unstructured":"Wen X, Wu QP, Ke S, Ellis L, Charnsangavej C, Delpassand AS, et al. Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225. J Nucl Med 2001;42:1530\u20137.","journal-title":"J Nucl Med"},{"key":"1370_CR8","first-page":"1683","volume":"45","author":"NR Schechter","year":"2004","unstructured":"Schechter NR, Wendt 3rd RE, Yang DJ, Azhdarinia A, Erwin WD, Stachowiak AM, et al. Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neck. J Nucl Med 2004;45:1683\u20137.","journal-title":"J Nucl Med"},{"key":"1370_CR9","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1158\/1078-0432.CCR-07-1119","volume":"13","author":"T Barrett","year":"2007","unstructured":"Barrett T, Koyama Y, Hama Y, Ravizzini G, Shin IS, Jang BS, et al. In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies. Clin Cancer Res 2007;13:6639\u201348.","journal-title":"Clin Cancer Res"},{"key":"1370_CR10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/cbr.2008.0493","volume":"23","author":"DE Milenic","year":"2008","unstructured":"Milenic DE, Wong KJ, Baidoo KE, Ray GL, Garmestani K, Williams M, et al. Cetuximab: preclinical evaluation of a monoclonal antibody targeting EGFR for radioimmunodiagnostic and radioimmunotherapeutic applications. Cancer Biother Radiopharm 2008;23:619\u201331.","journal-title":"Cancer Biother Radiopharm"},{"key":"1370_CR11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1089\/cbr.2007.0444","volume":"23","author":"W Ping Li","year":"2008","unstructured":"Ping Li W, Meyer LA, Capretto DA, Sherman CD, Anderson CJ. Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors. Cancer Biother Radiopharm 2008;23:158\u201371.","journal-title":"Cancer Biother Radiopharm"},{"key":"1370_CR12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s00259-006-0361-6","volume":"34","author":"W Cai","year":"2007","unstructured":"Cai W, Chen K, He L, Cao Q, Koong A, Chen X. Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody. Eur J Nucl Med Mol Imaging 2007;34:850\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1370_CR13","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.2967\/jnumed.108.052316","volume":"49","author":"M Eiblmaier","year":"2008","unstructured":"Eiblmaier M, Meyer LA, Watson MA, Fracasso PM, Pike LJ, Anderson CJ. Correlating EGFR expression with receptor-binding properties and internalization of 64Cu-DOTA-cetuximab in 5 cervical cancer cell lines. J Nucl Med 2008;49:1472\u20139.","journal-title":"J Nucl Med"},{"key":"1370_CR14","first-page":"1898","volume":"46","author":"LR Perk","year":"2005","unstructured":"Perk LR, Visser GW, Vosjan MJ, Stigter-van Walsum M, Tijink BM, Leemans CR, et al. (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab. J Nucl Med 2005;46:1898\u2013906.","journal-title":"J Nucl Med"},{"key":"1370_CR15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2967\/jnumed.108.054312","volume":"50","author":"HJ Aerts","year":"2009","unstructured":"Aerts HJ, Dubois L, Perk L, Vermaelen P, van Dongen GA, Wouters BG, et al. Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET. J Nucl Med 2009;50:123\u201331.","journal-title":"J Nucl Med"},{"key":"1370_CR16","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1021\/bc800039e","volume":"19","author":"CA Boswell","year":"2008","unstructured":"Boswell CA, Regino CA, Baidoo KE, Wong KJ, Bumb A, Xu H, et al. Synthesis of a cross-bridged cyclam derivative for peptide conjugation and 64Cu radiolabeling. Bioconjug Chem 2008;19:1476\u201384.","journal-title":"Bioconjug Chem"},{"key":"1370_CR17","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1021\/jm030383m","volume":"47","author":"CA Boswell","year":"2004","unstructured":"Boswell CA, Sun X, Niu W, Weisman GR, Wong EH, Rheingold AL, et al. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. J Med Chem 2004;47:1465\u201374.","journal-title":"J Med Chem"},{"key":"1370_CR18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1021\/bc800299f","volume":"20","author":"TK Nayak","year":"2009","unstructured":"Nayak TK, Brechbiel MW. Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges. Bioconjug Chem 2009;20:825\u201341.","journal-title":"Bioconjug Chem"},{"key":"1370_CR19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0969-8051(02)00322-0","volume":"29","author":"K Garmestani","year":"2002","unstructured":"Garmestani K, Milenic DE, Plascjak PS, Brechbiel MW. A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled herceptin. Nucl Med Biol 2002;29:599\u2013606.","journal-title":"Nucl Med Biol"},{"key":"1370_CR20","first-page":"1148","volume":"44","author":"S Palm","year":"2003","unstructured":"Palm S, Enmon RM Jr, Matei C, Kolbert KS, Xu S, Zanzonico PB, et al. Pharmacokinetics and biodistribution of (86)Y-trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative microPET and MRI. J Nucl Med 2003;44:1148\u201355.","journal-title":"J Nucl Med"},{"key":"1370_CR21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/bc00016a014","volume":"3","author":"CG Pippin","year":"1992","unstructured":"Pippin CG, Parker TA, McMurry TJ, Brechbiel MW. Spectrophotometric method for the determination of a bifunctional DTPA ligand in DTPA-monoclonal antibody conjugates. Bioconjug Chem 1992;3:342\u20135.","journal-title":"Bioconjug Chem"},{"key":"1370_CR22","doi-asserted-by":"crossref","DOI":"10.1201\/b14095","volume-title":"Pharmacokinetics","author":"M Gibaldi","year":"1982","unstructured":"Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Dekker; 1982.","edition":"2"},{"key":"1370_CR23","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1109\/TNS.2003.817282","volume":"50","author":"J Seidel","year":"2003","unstructured":"Seidel J, Vaquero JJ, Green MV. Resolution uniformity and sensitivity of the NIH ATLAS small animal PET scanner: comparison to simulated LSO scanners without depth-of-interaction capability. IEEE Trans Nucl Sci 2003;50:1347\u201350.","journal-title":"IEEE Trans Nucl Sci"},{"key":"1370_CR24","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.drudis.2008.05.009","volume":"13","author":"WC Eckelman","year":"2008","unstructured":"Eckelman WC, Reba RC, Kelloff GJ. Targeted imaging: an important biomarker for understanding disease progression in the era of personalized medicine. Drug Discov Today 2008;13:748\u201359.","journal-title":"Drug Discov Today"},{"key":"1370_CR25","first-page":"2363","volume":"36","author":"PD Cutler","year":"1995","unstructured":"Cutler PD, Schwarz SW, Anderson CJ, Connett JM, Welch MJ, Philpott GW, et al. Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso. J Nucl Med 1995;36:2363\u201371.","journal-title":"J Nucl Med"},{"key":"1370_CR26","first-page":"1818","volume":"36","author":"GW Philpott","year":"1995","unstructured":"Philpott GW, Schwarz SW, Anderson CJ, Dehdashti F, Connett JM, Zinn KR, et al. RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. J Nucl Med 1995;36:1818\u201324.","journal-title":"J Nucl Med"},{"key":"1370_CR27","doi-asserted-by":"crossref","unstructured":"Perk LR, Vosjan MJ, Visser GW, Budde M, Jurek P, Kiefer GE, et al. p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging. Eur J Nucl Med Mol Imaging 2009. doi: 10.1007\/s00259-009-1263-1 .","DOI":"10.1007\/s00259-009-1263-1"},{"key":"1370_CR28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jnci\/83.2.97","volume":"83","author":"CR Divgi","year":"1991","unstructured":"Divgi CR, Welt S, Kris M, Real FX, Yeh SD, Gralla R, et al. Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J Natl Cancer Inst 1991;83:97\u2013104.","journal-title":"J Natl Cancer Inst"},{"key":"1370_CR29","volume-title":"Cetuximab: epidermal growth factor receptor (EGFR) antibody, version 9.0","author":"ImClone","year":"2003","unstructured":"ImClone. Cetuximab: epidermal growth factor receptor (EGFR) antibody, version 9.0. New York: ImClone Systems, Inc; 2003."},{"key":"1370_CR30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.nucmedbio.2009.01.019","volume":"36","author":"X Liu","year":"2009","unstructured":"Liu X, Laforest R. Quantitative small animal PET imaging with nonconventional nuclides. Nucl Med Biol 2009;36:551\u20139.","journal-title":"Nucl Med Biol"},{"key":"1370_CR31","first-page":"159","volume":"52","author":"H Herzog","year":"2008","unstructured":"Herzog H, Tellmann L, Scholten B, Coenen HH, Qaim SM. PET imaging problems with the non-standard positron emitters yttrium-86 and iodine-124. Q J Nucl Med Mol Imaging 2008;52:159\u201365.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1370_CR32","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1200\/JCO.2008.18.0786","volume":"26","author":"F Nicolantonio Di","year":"2008","unstructured":"Di Nicolantonio F, Martini M, Molinari F, Sartore-Bianchi A, Arena S, Saletti P, et al. Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol 2008;26:5705\u201312.","journal-title":"J Clin Oncol"},{"key":"1370_CR33","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1200\/JCO.2007.14.7116","volume":"26","author":"RG Amado","year":"2008","unstructured":"Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 2008;26:1626\u201334.","journal-title":"J Clin Oncol"},{"key":"1370_CR34","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1200\/JCO.2008.19.8168","volume":"27","author":"A Jimeno","year":"2009","unstructured":"Jimeno A, Messersmith WA, Hirsch FR, Franklin WA, Eckhardt SG. KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection. J Clin Oncol 2009;27:1130\u20136.","journal-title":"J Clin Oncol"},{"key":"1370_CR35","doi-asserted-by":"crossref","unstructured":"Tolmachev V, Rosik D, Wallberg H, Sjoberg A, Sandstrom M, Hansson M, et al. Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR (111)In-DOTA-Z (EGFR:2377) Affibody molecule: aspect of the injected tracer amount. Eur J Nucl Med Mol Imaging 2009. doi: 10.1007\/s00259-009-1283-x .","DOI":"10.1007\/s00259-009-1283-x"},{"key":"1370_CR36","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2967\/jnumed.107.048538","volume":"49","author":"LO Gainkam","year":"2008","unstructured":"Gainkam LO, Huang L, Caveliers V, Keyaerts M, Hernot S, Vaneycken I, et al. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT\/micro-CT. J Nucl Med 2008;49:788\u201395.","journal-title":"J Nucl Med"},{"key":"1370_CR37","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2967\/jnumed.109.062117","volume":"50","author":"E Mishani","year":"2009","unstructured":"Mishani E, Hagooly A. Strategies for molecular imaging of epidermal growth factor receptor tyrosine kinase in cancer. J Nucl Med 2009;50:1199\u2013202.","journal-title":"J Nucl Med"},{"key":"1370_CR38","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.2174\/138161208786404326","volume":"14","author":"E Mishani","year":"2008","unstructured":"Mishani E, Abourbeh G, Eiblmaier M, Anderson CJ. Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities. Curr Pharm Des 2008;14:2983\u201398.","journal-title":"Curr Pharm Des"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1370-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-009-1370-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1370-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T20:53:02Z","timestamp":1634935982000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-009-1370-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,13]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["1370"],"URL":"https:\/\/doi.org\/10.1007\/s00259-009-1370-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,13]]}}}